Newswise Breaking News Channel: Meningitis

TRANSCRIPT AND VIDEO AVAILABLE Live Event for April 21: Sleeping pill reduces levels of Alzheimer's proteins

Newswise — Fri, 21 Apr 2023 15:10:43 EST

Researcher will discuss the study which involved a sleeping aid known as suvorexant that is already approved by the Food and Drug Administration (FDA) for insomnia, hints at the potential of sleep medications to slow or stop the progression of Alzheimer's disease.

Preventing the next pandemic: Leaders of Pacific Rim Universities meet in Bangkok, Thailand

Newswise — Mon, 14 Nov 2022 10:05:52 EST

Hosted by Chulalongkorn University the APRU APEC University Leaders' Forum 2022 is the first post-pandemic in-person APEC meeting held to foster high-level dialogue between CEOs, policy leaders, university presidents, and top researchers. This event begins Nov 15 at 9 PM EST.

Preventing and Treating Swimmer's Ear

UT Southwestern Medical Center — Wed, 13 Jul 2022 14:35:52 EST

Summertime trips to lakes or pools to escape the heat can sometimes lead to ear infections caused by excess moisture in the ear canal. Hongzhao Ji, M.D., Assistant Professor of Otolaryngology - Head and Neck Surgery at UT Southwestern, offers information on swimmer's ear, how to treat it, and how to prevent it.

VIDEO AND TRANSCRIPT AVAILABLE: Breakthrough Cases and COVID Boosters: Live Expert Panel for August 18, 2021

Newswise — Thu, 19 Aug 2021 15:00:13 EST

Expert Q&A: Do breakthrough cases mean we will soon need COVID boosters? The extremely contagious Delta variant continues to spread, prompting mask mandates, proof of vaccination, and other measures. Media invited to ask the experts about these and related topics.

A Rapid Test for Fungus That Caused Injection Deaths Is Announced

Rutgers University — Wed, 09 Jan 2013 13:45:00 EST

A rapid detection assay has been developed to Exserhilum rostratum, the fungus primarily responsible for 39 deaths among patients injected last year with a contaminated steroid medication. The test can be used both for patient samples and for detection of contamination in lots of medication.

Report Details How the Fungal Meningitis Outbreak Evolved and the Complexities of Providing Treatments

Michigan Medicine - University of Michigan — Wed, 24 Oct 2012 06:00:00 EST

As the number of fungal meningitis cases continues to rise, physicians across the country are faced with how best to provide the early treatment that can save lives. A University of Michigan Health System infectious disease expert is the lead author of a New England Journal of Medicine report detailing how the outbreak evolved and the complexities of providing anti-fungal treatments.

George Washington University Experts Available to Comment on the Meningitis and Pharmaceutical Regulatory Problems

George Washington University — Tue, 23 Oct 2012 10:15:00 EST

Expert: Fungus at Heart of Meningitis Outbreak Rarely a Threat

Cornell University — Thu, 18 Oct 2012 09:30:00 EST

Kathie Hodge, an associate professor of mycology, teaches medical and veterinary mycology and is an expert on the biodiversity of fungi. She comments on the fungus Exserohilum, the main culprit in the meningitis outbreak linked to contaminated medication that has claimed 42 lives and sickened almost 250 people in the United States.

Expert Physicians Address Fungal Meningitis Outbreak

American Society of Anesthesiologists (ASA) — Mon, 15 Oct 2012 07:00:00 EST

Four experts in anesthesiology, infectious disease and pain medicine discussed the recent U.S. meningitis outbreak in the Late-Breaking Education Panel, "The Fungal Meningitis Crisis," on Sunday, Oct. 14.

UMDNJ Expert Available on the Fungus Aspergillus

Rutgers University — Thu, 11 Oct 2012 11:20:00 EST

U-M Experts Available to Address Meningitis, Pharmaceutical Regulations

University of Michigan — Tue, 09 Oct 2012 15:45:00 EST

There are now more than 100 confirmed cases and eight deaths from a national outbreak of fungal meningitis linked to steroid injections, according to the Centers of Disease Control and Prevention. The steroid manufacturer, the New England Compounding Center, has issued a recall while health officials determine how many people may have received the injections for back pain. Nine states have reported cases and 23 received the recalled product.